Emyria Ltd's ultra-pure CBD capsule outperforms TGA-approved CBD treatment in pre-clinical animal trial
“These animal study results suggest Emyria has developed a novel, high performing and cost-effective CBD capsule that can meet the strict...
Stay updated with breaking news from Calvert Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“These animal study results suggest Emyria has developed a novel, high performing and cost-effective CBD capsule that can meet the strict...
“This preclinical work will help strengthen Emyria’s intellectual property relating to our synthetic cannabinoid platform. Importantly, this work will...
China stocks, China small caps, comment, analysis, financial news, news, mining news, oil and gas news on small cap companies on the Hong Kong, Shenzhen, Shanghai, Australian Stock Exchange, Toronto Stock Exchange, NYSE, NASDAQ and London Stock Exchange and AIM markets in China, Australia, Canada and the UK.
Tryp has also entered into an agreement with Gad Consulting Services to collaborate on the preclinical studies San Diego, California--(Newsfile Corp. - August 10, 2021) - Tryp Therapeutics (CSE: TRYP)